Counterpoint Quantitative Equity Etf Performance
| CPAI Etf | USD 42.67 0.05 0.12% |
The etf shows a Beta (market volatility) of 1.1, which signifies a somewhat significant risk relative to the market. Counterpoint Quantitative returns are very sensitive to returns on the market. As the market goes up or down, Counterpoint Quantitative is expected to follow.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Counterpoint Quantitative Equity are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Counterpoint Quantitative may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
1 | Counterpoint Quantitative Equity ETF Announces Annual Dividend of 0.36 | 12/12/2025 |
Counterpoint | Build AI portfolio with Counterpoint Etf |
Counterpoint Quantitative Relative Risk vs. Return Landscape
If you would invest 3,941 in Counterpoint Quantitative Equity on November 11, 2025 and sell it today you would earn a total of 326.00 from holding Counterpoint Quantitative Equity or generate 8.27% return on investment over 90 days. Counterpoint Quantitative Equity is currently generating 0.1362% in daily expected returns and assumes 1.2688% risk (volatility on return distribution) over the 90 days horizon. In different words, 11% of etfs are less volatile than Counterpoint, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Counterpoint Quantitative Target Price Odds to finish over Current Price
The tendency of Counterpoint Etf price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 42.67 | 90 days | 42.67 | about 21.51 |
Based on a normal probability distribution, the odds of Counterpoint Quantitative to move above the current price in 90 days from now is about 21.51 (This Counterpoint Quantitative Equity probability density function shows the probability of Counterpoint Etf to fall within a particular range of prices over 90 days) .
Counterpoint Quantitative Price Density |
| Price |
Predictive Modules for Counterpoint Quantitative
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Counterpoint Quantitative. Regardless of method or technology, however, to accurately forecast the etf market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the etf market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Counterpoint Quantitative Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Counterpoint Quantitative is not an exception. The market had few large corrections towards the Counterpoint Quantitative's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Counterpoint Quantitative Equity, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Counterpoint Quantitative within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.05 | |
β | Beta against Dow Jones | 1.10 | |
σ | Overall volatility | 2.13 | |
Ir | Information ratio | 0.04 |
Counterpoint Quantitative Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Counterpoint Quantitative for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Counterpoint Quantitative can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Net Loss for the year was (5.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Counterpoint Quantitative Equity currently holds about 5.29 K in cash with (72.58 K) of positive cash flow from operations. | |
| Roughly 65.0% of the company shares are held by company insiders | |
| The fund holds all of the assets under management (AUM) in different types of exotic instruments |
Counterpoint Quantitative Fundamentals Growth
Counterpoint Etf prices reflect investors' perceptions of the future prospects and financial health of Counterpoint Quantitative, and Counterpoint Quantitative fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Counterpoint Etf performance.
| Return On Asset | -13.96 | |||
| Current Valuation | 855.13 K | |||
| Shares Outstanding | 121.81 M | |||
| Cash And Equivalents | 5.29 K | |||
| Total Debt | 115.25 K | |||
| Book Value Per Share | (0.02) X | |||
| Cash Flow From Operations | (72.58 K) | |||
| Total Asset | 27.76 K | |||
| Retained Earnings | (7.49 M) | |||
| Current Asset | 20 K | |||
| Current Liabilities | 2.34 M | |||
About Counterpoint Quantitative Performance
By evaluating Counterpoint Quantitative's fundamental ratios, stakeholders can gain valuable insights into Counterpoint Quantitative's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Counterpoint Quantitative has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Counterpoint Quantitative has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Champion Pain Care Corporation operates as a pain management company in the United States. Champion Pain Care Corporation was incorporated in 2009 and is based in New York, New York. CHAMPION PAIN operates under Medical Care Facilities classification in the United States and is traded on PNK Exchange.| Net Loss for the year was (5.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Counterpoint Quantitative Equity currently holds about 5.29 K in cash with (72.58 K) of positive cash flow from operations. | |
| Roughly 65.0% of the company shares are held by company insiders | |
| The fund holds all of the assets under management (AUM) in different types of exotic instruments |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Counterpoint Quantitative Equity. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
The market value of Counterpoint Quantitative is measured differently than its book value, which is the value of Counterpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Counterpoint Quantitative's value that differs from its market value or its book value, called intrinsic value, which is Counterpoint Quantitative's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Counterpoint Quantitative's market value can be influenced by many factors that don't directly affect Counterpoint Quantitative's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Counterpoint Quantitative's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Counterpoint Quantitative should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Counterpoint Quantitative's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.